ロード中...
First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent
We previously identified ONC201 (TIC10) as a first-in-class orally active small molecule with robust antitumor activity that is currently in clinical trials in advanced cancers. Here, we further investigate the safety characteristics of ONC201 in preclinical models that reveal an excellent safety pr...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4651306/ https://ncbi.nlm.nih.gov/pubmed/26580220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0143082 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|